EHA | European Hematology Association
EHA 2024
Promising Avenues for the Development of Personalized Treatment for FVII Deficiency
/ Maria Eugenia Chollet
An Excellent Target with a Wide Therapeutic Window in del(5q) Myeloid Malignancies
/ Sergio Martinez Høyer
Development of Prediction Models for Survival among Hodgkin Lymphoma Patients
/ Rasmus Rask Kragh Jørgensen
Better Predictor of Treatment Efficacy of Myelodysplastic Syndromes
/ Ângela Sofia Gerós Mesquita